National Pregnancy Registry for Psychiatric Medications
Massachusetts General Hospital · with Alkermes, Inc., Eisai Inc. · NCT01246765
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–45 · Women only
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 5000
- US sites recruiting
- 1
- Study start
- November 2008
- Record last updated
- October 24, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The National Pregnancy Registry for Psychiatric Medications is dedicated to evaluating the safety of psychiatric medications such as antidepressants, ADHD medications, sedative hypnotics, and atypical antipsychotics that many people take during pregnancy to treat a wide range of mood, anxiety, executive function, or psychiatric disorders. The goal of this Registry is to gather information on the safety of these medications during pregnancy, as current data is limited.
Conditions: Pregnant Women; Psychotropic Drugs
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Pregnant women
- Age 18-45
- Subjects will be willing to participate over the phone
- Subjects will be able to provide informed consent
Exclusion Criteria
- Women who have completed their pregnancy
- Women who are planning to become pregnant
- Women who are not taking any psychiatric medications and/or have no history of psychiatric illness
Recruiting US locations
Massachusetts General Hospital
Boston, MA 02114
Site contact: Bryn Rediger, BA · (617) 724-8020 · admin@womensmentalhealth.org
Study contacts (from the official record)
- Bryn Rediger · (617) 724-8020 · brediger@partners.org
- Lee Cohen, MD · (617) 724-8020 · lcohen2@partners.org
Similar studies in Massachusetts
All mental health studies in Massachusetts →- RecruitingPhase 1/Phase 2Overnight stay mentioned
A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed Immediate-release Lithium Carbonate Capsule in Subjects With Bipolar I Disorder
Alzamend Neuro, Inc.
- Location
- Boston, MA
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1/Phase 2
PET Brain Imaging in Multiple Sclerosis, Alzheimer's Disease, and Other Neurological and Neuropsychiatric Diseases
Brigham and Women's Hospital
- Location
- Boston, MA
- Eligibility basics
- Ages 18–85
- RecruitingHealthy volunteers
Observational Study of Decentralized Urine Optical Interaction Patterns Associated With Environmental Microplastic and Nanoplastic Exposure
Ecotera Health LLC
- Location
- Boston, MA + 50 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 3
REVEAL Study - Diagnostic Testing for PTSD Using the Senseye Diagnostic Tool
Senseye, Inc.
- Location
- Boston, MA + 2 other US sites
- Eligibility basics
- Ages 18+